Diagnostic Kit for BNP (Time-resolved Fluorescence Immunochromatographic Assay)

Primary DI

06974521000495

Basic UDI-DI Code

B-06974521000495

Reference

SUPF027025

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Shenzhen Superbio Technology Co.,Ltd.

This kit is suitable for in vitro quantitative detection of the concentration of Brain Natriuretic Peptide (BNP) in human plasma and whole blood. This product is used for testing in medical and health institutions as an aid in the diagnosis of heart failure and its prognosis. Brain natriuretic peptide (BNP), also known as B-type natriuretic peptide (BNP), is mainly synthesized by ventricles. It is initially synthesized as a B-type natriuretic peptide precursor (pre-proBNP) with 134 amino acids. After that, the signal peptide of 26 amino acids at the N-terminal is cut off to form pro-B-type natriuretic peptide (proBNP) containing 108 amino acids, which is further cut into N-terminal B-type natriuretic peptide (also called N-terminal pro brain natriuretic peptide, NT-proBNP) with 76 amino acids at N-terminal and BNP with 32 amino acids at C-terminal by endopeptidase fufin. NT-proBNP and BNP are released into the blood at the same time. Compared with NT-proBNP, the concentration of BNP in blood can more specifically reflect the situation of ventricular. BNP is more valuable in the prognosis of patients with heart failure.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).